EP2157979 - CALCIUM CHANNEL PROTEINS AND USES THEREOF [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 17.05.2019 Database last updated on 02.09.2024 | |
Former | The patent has been granted Status updated on 08.06.2018 | ||
Former | Grant of patent is intended Status updated on 22.05.2018 | ||
Former | Examination is in progress Status updated on 10.04.2018 | ||
Former | Grant of patent is intended Status updated on 26.11.2017 | ||
Former | Examination is in progress Status updated on 02.10.2017 | ||
Former | Grant of patent is intended Status updated on 21.05.2017 | ||
Former | Examination is in progress Status updated on 10.05.2017 | Most recent event Tooltip | 23.07.2021 | Lapse of the patent in a contracting state New state(s): MT | published on 25.08.2021 [2021/34] | Applicant(s) | For all designated states Calcimedica, Inc. 505 Coast Blvd S., Ste 209 La Jolla, CA 92037 / US | [2010/09] | Inventor(s) | 01 /
STAUDERMAN, Kenneth, A. 3615 Lotus Drive San Diego, CA 92106 / US | 02 /
ROOS, Jack 10527 Stony Ridge Ct. San Diego, CA 92131 / US | 03 /
VELICELEBI, Gonul 4688 Tarantella Lane San Diego, CA 92130 / US | [2010/09] | Representative(s) | Avidity IP Broers Building Hauser Forum 21 JJ Thomson Avenue Cambridge CB3 0FA / GB | [2018/28] |
Former [2010/09] | Cole, William Gwyn, et al HLBBshaw Merlin House Falconry Court Baker's Lane Epping, Essex CM16 5DQ / GB | Application number, filing date | 08756325.0 | 27.05.2008 | [2010/09] | WO2008US64915 | Priority number, date | US20070939922P | 24.05.2007 Original published format: US 939922 P | [2010/09] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2008148108 | Date: | 04.12.2008 | Language: | EN | [2008/49] | Type: | A1 Application with search report | No.: | EP2157979 | Date: | 03.03.2010 | Language: | EN | The application published by WIPO in one of the EPO official languages on 04.12.2008 takes the place of the publication of the European patent application. | [2010/09] | Type: | B1 Patent specification | No.: | EP2157979 | Date: | 11.07.2018 | Language: | EN | [2018/28] | Search report(s) | International search report - published on: | KR | 04.12.2008 | (Supplementary) European search report - dispatched on: | EP | 25.05.2010 | Classification | IPC: | A61K38/17, C07H21/04, C07K14/435 | [2010/09] | CPC: |
G01N33/5008 (EP,US);
G01N33/5076 (EP,US);
G01N33/6872 (EP,US);
G01N2333/705 (EP,US)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2018/28] |
Former [2010/09] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR | Title | German: | KALZIUMKANALPROTEINE UND IHRE VERWENDUNGEN | [2010/09] | English: | CALCIUM CHANNEL PROTEINS AND USES THEREOF | [2010/09] | French: | PROTÉINES DE CANAL DE CALCIUM ET LEUR UTILISATION | [2010/09] | Entry into regional phase | 17.12.2009 | National basic fee paid | 17.12.2009 | Search fee paid | 17.12.2009 | Designation fee(s) paid | 17.12.2009 | Examination fee paid | Examination procedure | 17.12.2009 | Examination requested [2010/09] | 05.04.2011 | Amendment by applicant (claims and/or description) | 04.04.2012 | Despatch of a communication from the examining division (Time limit: M06) | 15.10.2012 | Reply to a communication from the examining division | 07.10.2013 | Despatch of a communication from the examining division (Time limit: M04) | 15.05.2014 | Reply to a communication from the examining division | 27.06.2014 | Despatch of a communication from the examining division (Time limit: M06) | 04.02.2015 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 13.04.2015 | Reply to a communication from the examining division | 24.07.2015 | Despatch of a communication from the examining division (Time limit: M04) | 26.11.2015 | Reply to a communication from the examining division | 09.05.2016 | Despatch of a communication from the examining division (Time limit: M04) | 02.08.2016 | Reply to a communication from the examining division | 22.05.2017 | Communication of intention to grant the patent | 27.09.2017 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 27.09.2017 | Fee for grant paid | 27.09.2017 | Fee for publishing/printing paid | 27.11.2017 | Communication of intention to grant the patent | 06.04.2018 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 22.05.2018 | Information about intention to grant a patent | 22.05.2018 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 04.04.2012 | Opposition(s) | 12.04.2019 | No opposition filed within time limit [2019/25] | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 13.04.2015 | Request for further processing filed | 13.04.2015 | Full payment received (date of receipt of payment) Request granted | 15.05.2015 | Decision despatched | The application is deemed to be withdrawn due to failure to reply to the examination report | 15.05.2014 | Request for further processing filed | 15.05.2014 | Full payment received (date of receipt of payment) Request granted | 30.05.2014 | Decision despatched | The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report | 05.04.2011 | Request for further processing filed | 05.04.2011 | Full payment received (date of receipt of payment) Request granted | 18.04.2011 | Decision despatched | Fees paid | Renewal fee | 25.06.2010 | Renewal fee patent year 03 | 25.05.2011 | Renewal fee patent year 04 | 25.05.2012 | Renewal fee patent year 05 | 10.05.2013 | Renewal fee patent year 06 | 12.06.2014 | Renewal fee patent year 07 | 12.05.2015 | Renewal fee patent year 08 | 27.05.2016 | Renewal fee patent year 09 | 30.05.2017 | Renewal fee patent year 10 | 29.05.2018 | Renewal fee patent year 11 | Penalty fee | Additional fee for renewal fee | 31.05.2010 | 03   M06   Fee paid on   25.06.2010 | 31.05.2014 | 07   M06   Fee paid on   12.06.2014 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 27.05.2008 | AT | 11.07.2018 | CY | 11.07.2018 | CZ | 11.07.2018 | EE | 11.07.2018 | ES | 11.07.2018 | HR | 11.07.2018 | IT | 11.07.2018 | LT | 11.07.2018 | LV | 11.07.2018 | MC | 11.07.2018 | MT | 11.07.2018 | PL | 11.07.2018 | RO | 11.07.2018 | SI | 11.07.2018 | SK | 11.07.2018 | TR | 11.07.2018 | BG | 11.10.2018 | NO | 11.10.2018 | GR | 12.10.2018 | IS | 11.11.2018 | PT | 11.11.2018 | [2021/34] |
Former [2021/32] | HU | 27.05.2008 | |
AT | 11.07.2018 | ||
CY | 11.07.2018 | ||
CZ | 11.07.2018 | ||
EE | 11.07.2018 | ||
ES | 11.07.2018 | ||
HR | 11.07.2018 | ||
IT | 11.07.2018 | ||
LT | 11.07.2018 | ||
LV | 11.07.2018 | ||
MC | 11.07.2018 | ||
PL | 11.07.2018 | ||
RO | 11.07.2018 | ||
SI | 11.07.2018 | ||
SK | 11.07.2018 | ||
TR | 11.07.2018 | ||
BG | 11.10.2018 | ||
NO | 11.10.2018 | ||
GR | 12.10.2018 | ||
IS | 11.11.2018 | ||
PT | 11.11.2018 | ||
Former [2021/26] | AT | 11.07.2018 | |
CY | 11.07.2018 | ||
CZ | 11.07.2018 | ||
EE | 11.07.2018 | ||
ES | 11.07.2018 | ||
HR | 11.07.2018 | ||
IT | 11.07.2018 | ||
LT | 11.07.2018 | ||
LV | 11.07.2018 | ||
MC | 11.07.2018 | ||
PL | 11.07.2018 | ||
RO | 11.07.2018 | ||
SI | 11.07.2018 | ||
SK | 11.07.2018 | ||
TR | 11.07.2018 | ||
BG | 11.10.2018 | ||
NO | 11.10.2018 | ||
GR | 12.10.2018 | ||
IS | 11.11.2018 | ||
PT | 11.11.2018 | ||
Former [2020/29] | AT | 11.07.2018 | |
CZ | 11.07.2018 | ||
EE | 11.07.2018 | ||
ES | 11.07.2018 | ||
HR | 11.07.2018 | ||
IT | 11.07.2018 | ||
LT | 11.07.2018 | ||
LV | 11.07.2018 | ||
MC | 11.07.2018 | ||
PL | 11.07.2018 | ||
RO | 11.07.2018 | ||
SI | 11.07.2018 | ||
SK | 11.07.2018 | ||
TR | 11.07.2018 | ||
BG | 11.10.2018 | ||
NO | 11.10.2018 | ||
GR | 12.10.2018 | ||
IS | 11.11.2018 | ||
PT | 11.11.2018 | ||
Former [2020/16] | AT | 11.07.2018 | |
CZ | 11.07.2018 | ||
EE | 11.07.2018 | ||
ES | 11.07.2018 | ||
HR | 11.07.2018 | ||
IT | 11.07.2018 | ||
LT | 11.07.2018 | ||
LV | 11.07.2018 | ||
MC | 11.07.2018 | ||
PL | 11.07.2018 | ||
RO | 11.07.2018 | ||
SI | 11.07.2018 | ||
SK | 11.07.2018 | ||
TR | 11.07.2018 | ||
BG | 11.10.2018 | ||
NO | 11.10.2018 | ||
GR | 12.10.2018 | ||
IS | 11.11.2018 | ||
Former [2020/07] | AT | 11.07.2018 | |
CZ | 11.07.2018 | ||
EE | 11.07.2018 | ||
ES | 11.07.2018 | ||
HR | 11.07.2018 | ||
IT | 11.07.2018 | ||
LT | 11.07.2018 | ||
LV | 11.07.2018 | ||
MC | 11.07.2018 | ||
PL | 11.07.2018 | ||
RO | 11.07.2018 | ||
SI | 11.07.2018 | ||
SK | 11.07.2018 | ||
BG | 11.10.2018 | ||
NO | 11.10.2018 | ||
GR | 12.10.2018 | ||
IS | 11.11.2018 | ||
Former [2019/37] | AT | 11.07.2018 | |
CZ | 11.07.2018 | ||
EE | 11.07.2018 | ||
ES | 11.07.2018 | ||
HR | 11.07.2018 | ||
IT | 11.07.2018 | ||
LT | 11.07.2018 | ||
LV | 11.07.2018 | ||
PL | 11.07.2018 | ||
RO | 11.07.2018 | ||
SI | 11.07.2018 | ||
SK | 11.07.2018 | ||
BG | 11.10.2018 | ||
NO | 11.10.2018 | ||
GR | 12.10.2018 | ||
IS | 11.11.2018 | ||
Former [2019/24] | AT | 11.07.2018 | |
CZ | 11.07.2018 | ||
EE | 11.07.2018 | ||
ES | 11.07.2018 | ||
HR | 11.07.2018 | ||
IT | 11.07.2018 | ||
LT | 11.07.2018 | ||
LV | 11.07.2018 | ||
PL | 11.07.2018 | ||
RO | 11.07.2018 | ||
SK | 11.07.2018 | ||
BG | 11.10.2018 | ||
NO | 11.10.2018 | ||
GR | 12.10.2018 | ||
IS | 11.11.2018 | ||
Former [2019/22] | AT | 11.07.2018 | |
CZ | 11.07.2018 | ||
ES | 11.07.2018 | ||
HR | 11.07.2018 | ||
IT | 11.07.2018 | ||
LT | 11.07.2018 | ||
LV | 11.07.2018 | ||
PL | 11.07.2018 | ||
RO | 11.07.2018 | ||
BG | 11.10.2018 | ||
NO | 11.10.2018 | ||
GR | 12.10.2018 | ||
IS | 11.11.2018 | ||
Former [2019/21] | AT | 11.07.2018 | |
ES | 11.07.2018 | ||
HR | 11.07.2018 | ||
IT | 11.07.2018 | ||
LT | 11.07.2018 | ||
LV | 11.07.2018 | ||
PL | 11.07.2018 | ||
BG | 11.10.2018 | ||
NO | 11.10.2018 | ||
GR | 12.10.2018 | ||
IS | 11.11.2018 | ||
Former [2019/12] | AT | 11.07.2018 | |
ES | 11.07.2018 | ||
HR | 11.07.2018 | ||
LT | 11.07.2018 | ||
LV | 11.07.2018 | ||
PL | 11.07.2018 | ||
BG | 11.10.2018 | ||
NO | 11.10.2018 | ||
GR | 12.10.2018 | ||
IS | 11.11.2018 | ||
Former [2019/11] | AT | 11.07.2018 | |
HR | 11.07.2018 | ||
LT | 11.07.2018 | ||
PL | 11.07.2018 | ||
BG | 11.10.2018 | ||
NO | 11.10.2018 | ||
GR | 12.10.2018 | ||
IS | 11.11.2018 | ||
Former [2019/10] | AT | 11.07.2018 | |
LT | 11.07.2018 | ||
PL | 11.07.2018 | ||
BG | 11.10.2018 | ||
NO | 11.10.2018 | ||
GR | 12.10.2018 | ||
IS | 11.11.2018 | ||
Former [2019/08] | LT | 11.07.2018 | |
NO | 11.10.2018 | ||
IS | 11.11.2018 | ||
Former [2019/07] | LT | 11.07.2018 | Documents cited: | Search | [XP]WO2007139926 (UNIV CALIFORNIA [US], et al) [XP] 1-10,13-15 * page 21 - page 22 *; | [A] - YEROMIN A V ET AL, "Molecular identification of the CRAC channel by altered ion selectivity in a mutant of Orai", NATURE, NATURE PUBLISHING GROUP, LONDON, GB LNKD- DOI:10.1038/NATURE05108, vol. 443, no. 7108, ISSN 0028-0836, (20060914), pages 226 - 229, (20060820), XP002489915 [A] 1-10,13-15 * the whole document * DOI: http://dx.doi.org/10.1038/nature05108 | [X] - STRANGE ET AL, "Physiological roles of STIM1 and Orai1 homologs and CRAC channels in the genetic model organism Caenorhabditis elegans", CELL CALCIUM (EDINBURGH), CHURCHILL LIVINGSTONE MEDICAL JOURNALS, EDINBURGH, GB LNKD- DOI:10.1016/J.CECA.2007.02.007, (20070321), vol. 42, no. 2, ISSN 0143-4160, pages 193 - 203, XP022136170 [X] 6-9 * the whole document * DOI: http://dx.doi.org/10.1016/j.ceca.2007.02.007 | [A] - PUTNEY ET AL, "Recent breakthroughs in the molecular mechanism of capacitative calcium entry (with thoughts on how we got here)", CELL CALCIUM (EDINBURGH), CHURCHILL LIVINGSTONE MEDICAL JOURNALS, EDINBURGH, GB, (20070308), vol. 42, no. 2, ISSN 0143-4160, pages 103 - 110, XP022136161 [A] 1-10,13-16 * the whole document * | International search | [X] - LORIN-NEBEL C. ET AL., "CRAC channel activity in C. elegans is mediated by orai1 and STIM1 homologues and is essential for ovulation and fertility", J. PHYSIOL., (2007), vol. 580, pages 67 - 85, XP008125064 DOI: http://dx.doi.org/10.1113/jphysiol.2006.124883 | [X] - SOBOLOFF J. ET AL., "Calcium signals mediated by STIM and Orai proteins-a new paradigm in inter-organelle communication", BIOCHIMICA, ET BIOPHYSICA ACTA, (2006), vol. 1763, pages 1161 - 1168, XP005776843 DOI: http://dx.doi.org/10.1016/j.bbamcr.2006.09.023 | [X] - SMYTH J.T. ET AL., "Emerging perspectives in store-prepared Ca2+entry: Roles of Orai, Stim and TRP", BIOCHIMICA ET BIOPHYSICA ACTA, (2006), vol. 1763, pages 1147 - 1160, XP005776842 DOI: http://dx.doi.org/10.1016/j.bbamcr.2006.08.050 | [Y] - KUHNS D.B. ET AL., "Ca2+-dependent production and release of IL-8 in human neutrophils", J. IMMUNOL., (1998), vol. 161, pages 4332 - 4339, XP008124922 | Examination | - PEINELT CHRISTINE ET AL, "Amplification of CRAC current by STIM1 and CRACM1 (Orai1)", NATURE CELL BIOLOGY, MACMILLAN MAGAZINES LTD, vol. 8, no. 7, doi:10.1038/NCB1435, ISSN 1465-7392, (20060701), pages 771 - 773,1, (20060530), XP002489913 DOI: http://dx.doi.org/10.1038/ncb1435 | - R Tsien ET AL, "Mechanisms of calcium channel modulation by [beta]-adrenergic agents and dihydropyridine calcium agonists", Journal of Molecular and Cellular Cardiology, (19860701), vol. 18, no. 7, doi:10.1016/S0022-2828(86)80941-5, ISSN 0022-2828, pages 691 - 710, XP055080963 DOI: http://dx.doi.org/10.1016/S0022-2828(86)80941-5 | by applicant | WO2007081804 | US2007031814 | US2007105160 | US2002034728 | - PUTNEY ET AL., CELL, (1993), vol. 75, pages 199 - 201 | - FAGAN ET AL., J BIOL. CHEM., (2000), vol. 275, pages 26530 - 26537 | - LEWIS, ANNU. REV. IMMUNOL., (2001), vol. 19, pages 497 - 521 | - NUNEZ ET AL., J PHYSIOL., (2006), pages 57 - 73 | - WINSLOW ET AL., CURR. OPIN. IMMUNOL., (2003), vol. 15, pages 299 - 307 | - J.C.MERCER ET AL., J BIOL. CHEMISTRY, (2006), vol. 281, pages 24979 - 24990 | - C. PEINELT ET AL., NATURE CELL BIOLOGY, (2006), vol. 8, pages 771 - 776 | - YEROMIN ET AL., J GEN. PHYSIOL., (2004), vol. 123, pages 167 - 182 | - CAREY; SUNDBERG, ADVANCED ORGANIC CHEMISTRY 4TH ED., PLENUM PRESS, (2000), vol. A | - CAREY; SUNDBERG, ADVANCED ORGANIC CHEMISTRY 4TH ED., PLENUM PRESS, (2001), vol. B | - STREB ET AL., NATURE, (1983), vol. 306, pages 67 - 69 | - PUTNEY, CELL CALCIUM, (1986), vol. 7, pages 1 - 12 | - PAREKH ET AL., PHYSIOL.REV., (2005), pages 757 - 810 | - PAREKH; PUTNEY, PHYSIOL. REV., (2005), vol. 85, pages 757 - 810 | - RAO ET AL., ANNU REV 1MMUNOL., (1997), vol. 15, pages 707 - 47 | - MACIAN ET AL., "Transcriptional mechanisms underlying lymphocyte tolerance", CELL, (20020614), vol. 109, no. 6, pages 719 - 31 | - WU ET AL., CELL, (20060728), vol. 126, no. 2, pages 375 - 87 | - RUDENSKY AY; GAVIN M; ZHENG Y, CELL, (20060728), vol. 126, no. 2, pages 253 - 256 | - MIYAWAKI ET AL., NATURE, (1997), vol. 388, pages 882 - 887 | - PARTISETI ET AL., JBIOL. CHEM., (1994), vol. 269, pages 32327 - 32335 | - FESKE ET AL., CURR. BIOL., (2005), vol. 15, pages 1235 - 1241 | - TREVILLYAN ET AL., J BIOL. CHEM., (2001), vol. 276, pages 48118 - 26 | - TREVILLYAN ET AL., J BIOL. CHEM, (2001), vol. 276, pages 48118 - 26 | - TREVILLYAN ET AL., J. BIOL. CHEM, (2001), vol. 276, pages 48118 - 26 | - XU ET AL., J APPL. PHYSIOL., (2002), vol. 93, pages 1833 - 1840 | - HUMBLES ET AL., PROC. NATL. ACAD. SCI., (2002), vol. 99, pages 1479 - 1484 | - JEFFERSON; JOHNSON, J NEPHROL., (1999), vol. 12, pages 297 - 307 | - HUMPHREYS-BEHER; PECK, ARCH. ORAL BIOL., (1999), vol. 44, no. 1, pages 21 - 25 | - BRAYER ET AL., J RHEUMATOL., (2000), vol. 27, pages 1896 - 1904 | - GRIFFITHS; REMMERS, IMMUNOL. REV., (2001), vol. 184, pages 172 - 183 | - CHAPLAN ET AL., J NEUROSCI. METHODS, (1994), vol. 53, pages 55 - 63 | - LUO ET AL., J NEUROSCI., (2001), vol. 21, pages 1868 - 1875 | - HOGABOAM CM ET AL., "An orally active non-selective endothelin receptor antagonist, bosentan, markedly reduces injury in a rat model of colitis", EUR PHARRNACOL., (1996), vol. 309, pages 261 - 269 | - YUE G ET AL., "In some cases, the 21-aminosteroid tirilazid mesylate ameliorates inflammatory bowel disease in rats", J PHMMACOL EXP THER., (1996), vol. 276, pages 265 - 270 |